These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19038694)

  • 1. Holidays, triggers, and willpower--is there a role for medications? A commentary on "The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients".
    Rosenbloom DL
    J Subst Abuse Treat; 2009 Jan; 36(1):7. PubMed ID: 19038694
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
    Lapham S; Forman R; Alexander M; Illeperuma A; Bohn MJ
    J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release naltrexone for treatment of alcohol dependence in primary care.
    Lee JD; Grossman E; DiRocco D; Truncali A; Hanley K; Stevens D; Rotrosen J; Gourevitch MN
    J Subst Abuse Treat; 2010 Jul; 39(1):14-21. PubMed ID: 20363090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
    O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
    J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular extended-release naltrexone: current evidence.
    Gastfriend DR
    Ann N Y Acad Sci; 2011 Jan; 1216():144-66. PubMed ID: 21272018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting injectable naltrexone for the treatment of alcohol dependence.
    Mannelli P; Peindl K; Masand PS; Patkar AA
    Expert Rev Neurother; 2007 Oct; 7(10):1265-77. PubMed ID: 17939765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of naltrexone in the treatment of alcohol dependence: oral versus injectable delivery.
    Roozen HG; de Waart R; van den Brink W
    Eur Addict Res; 2007; 13(4):201-6. PubMed ID: 17851241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-beta-naltrexol reduces alcohol consumption in rats.
    Rukstalis MR; Stromberg MF; O'Brien CP; Volpicelli JR
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1593-6. PubMed ID: 11045869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
    Krishnan-Sarin S; Krystal JH; Shi J; Pittman B; O'Malley SS
    Biol Psychiatry; 2007 Sep; 62(6):694-7. PubMed ID: 17336941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts.
    Finigan MW; Perkins T; Zold-Kilbourn P; Parks J; Stringer M
    J Subst Abuse Treat; 2011 Oct; 41(3):288-93. PubMed ID: 21696912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months.
    Lee JD; Grossman E; Huben L; Manseau M; McNeely J; Rotrosen J; Stevens D; Gourevitch MN
    J Subst Abuse Treat; 2012 Dec; 43(4):458-62. PubMed ID: 22985676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vivitrex (Alkermes/Cephalon).
    Heading CE
    Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates.
    Weinrieb RM; Van Horn DH; McLellan AT; Volpicelli JR; Calarco JS; Lucey MR
    J Addict Dis; 2001; 20(2):105-19. PubMed ID: 11318394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of depot naltrexone under legal coercion: the case for caution.
    Hall W; Capps B; Carter A
    Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies to maximize the efficacy of naltrexone for alcohol dependence.
    O'Malley SS
    NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of information in naltrexone study.
    Rastegar DA
    Arch Gen Psychiatry; 2007 Jul; 64(7):865; author reply 865. PubMed ID: 17606820
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral consequences of repeated nicotine during adolescence in alcohol-preferring AA and alcohol-avoiding ANA rats.
    Kemppainen H; Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2009 Feb; 33(2):340-9. PubMed ID: 19032573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release intramuscular naltrexone: a viewpoint by Falk Kiefer.
    Kiefer F
    Drugs; 2006; 66(13):1752-3. PubMed ID: 16978039
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers.
    Kranzler HR; Armeli S; Feinn R; Tennen H
    J Consult Clin Psychol; 2004 Apr; 72(2):317-27. PubMed ID: 15065964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.